Developer docs
API playgroundTry for free, no card

Search company profiles

Abarca Health

Full company profile

uuid0007ysf

Namestring
Abarca Health
Legal namestring
Abarca Health, LLC
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Abarca Health, founded in 2005 and headquartered in San Juan, Puerto Rico, is an independent, privately-held pharmacy benefit manager (PBM) serving commercial health plans, Medicare Advantage plans, Medicaid programs, and self-insured employers across all 50 U.S. states. The company manages approximately $14 billion in annual drug spend for 7.5 million lives and processes 220 million prescription claims per year, positioning itself as a transparent, non-spread-pricing alternative to the three dominant vertically-integrated PBMs (CVS Caremark, Express Scripts, OptumRx) that collectively control roughly 80% of the U.S. market.

Abarca's core technology is Darwin, a proprietary, cloud-based, in-house-built next-generation PBM platform that unifies claims processing, rebate administration, payments, invoicing, clinical tools, analytics, and member engagement into a single integrated system. The platform incorporates AI-powered clinical reasoning for prior authorization, predictive analytics over five years of historical utilization data, real-time benefit decision support, and adherence anomaly detection. Darwin is supplemented by Assura, a net cost guarantee pricing model that fixes per-script drug costs annually with quarterly reconciliation; RxTarget for medication adherence targeting; RxIntelligence reporting; and Coverage Determinations modules. In December 2025, Abarca launched two new Better Care programs — Better Balance (AI-powered cardiometabolic care in partnership with Welldoc) and Better Access (specialty pharmacy fulfillment in partnership with Free Market Health and Amazon Pharmacy).

Abarca earns revenue through managed-services administrative fees, claims-processing fees, manufacturer rebates (including value-based contracts such as the pioneering 2017 Biogen Medicaid agreement for MS therapies), and Assura subscription-style net cost guarantee pricing. The company holds URAC PBM accreditation, HITRUST CSF certification, ISO 22301 business continuity certification, and HIPAA compliance. In June 2026, Abarca announced a strategic combination with LucyRx to form Healthcare Revolution Partners, scaling combined membership to 9M+ plan members across commercial and government clients, with the deal expected to close in Q3 2026 pending regulatory approval. The company employs 650+ people (35%+ fully remote), with a secondary office in Florida, and is led by founder and CEO Jason Borschow alongside COO Adriana Ramirez, CTO Juan C. Ruiz, CIO Serge Perras, CPO Mercibel Gonzalez, and CGO Javier Gonzalez.

Short descriptiontext

Abarca Health is an independent, Puerto Rico-based pharmacy benefit manager that uses its proprietary Darwin platform to manage $14B in annual drug spend for 7.5M lives across commercial, Medicare, and Medicaid health plans in all 50 U.S. states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSan Juan Capistrano, United States
HQ citystring
San Juan Capistrano
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy benefit management, drug spend management, prescription claims processing, specialty pharmacy services, PBM technology platform
Industry2 codes
PRIMARYHLAEAKAC
Claims Processing, Adjudication & Payment Integrity
SECONDARYHLAEAKAE
Specialty Pharmacy Benefit Management (Specialty PBM)
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code1 code
  • Hospital & Medical Service Plans6324
Product category
Pharmacy Benefit Management
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmacy Benefit Management Services
TypeManaged Services
Description

Abarca earns revenue by managing prescription drug benefits for health plans, self-insured employers, and government programs. Revenue is generated through administrative fees, claims processing fees, and rebates negotiated with pharmaceutical manufacturers.

abarcahealth.com
2Net Cost Guarantee (Assura)
TypeSubscription Recurring
Description

Abarca guarantees net cost of drugs through annual fixed per-script pricing, with quarterly reconciliation payments to clients. This creates predictable drug spend management revenue while aligning incentives.

abarcahealth.com
3Value-Based Agreements
TypeTransaction Fee
Description

Outcome-based contracts with pharmaceutical manufacturers where rebates are tied to medication adherence and patient outcomes, particularly for specialty medications.

abarcahealth.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1Darwin
Description

Next-generation PBM platform that is fully integrated and user-friendly, providing business intelligence, claims processing, and reporting capabilities.

abarcahealth.com
+6 more records
Core offering1 text field

Abarca Health is a privately held pharmacy benefit manager (PBM) that manages prescription drug benefits for commercial health plans, Medicare and Medicaid programs, and self-insured employers across the United States. Its core offering is Darwin, a proprietary cloud-based PBM platform built in-house that integrates claims processing, rebate administration, payments, invoicing, clinical tools, predictive analytics, and member engagement. Complementing the platform are Assura net-cost-guarantee pricing, the Better Balance AI-powered cardiometabolic care program, the Better Access specialty pharmacy fulfillment program, and the Triple-S en Casa home delivery pharmacy program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • $14 billion in annual drug spend managed
+5 more records
Product overview1 text field

Abarca Health operates as a pharmacy benefit manager (PBM) offering a unified platform-plus-modules architecture. The core offering centers on Darwin, a proprietary next-generation PBM platform that integrates claims processing, rebates, payments, clinical tools, and analytics. This platform is complemented by financial tools (Assura for net cost guarantees), clinical programs under the Better Care umbrella (Better Balance for AI-powered cardiometabolic care, Better Access for specialty pharmacy fulfillment), and additional modules including RxIntelligence for reporting, RxTarget for adherence, Coverage Determinations, and a home delivery app. Following the June 2026 merger with LucyRx, the combined entity now also incorporates LucyRx's Connected Specialty Care Network, serving over 9 million members across commercial and government clients under parent company Healthcare Revolution Partners.

Product and service6 records
1Darwin
CategoryPharmacy Benefit Management Platform
Description

Abarca's next-generation, cloud-based PBM platform built in-house for intelligent, flexible, and user-friendly pharmacy benefit management. Integrates claims processing, rebates, payments, clinical tools, analytics with five years of historical data, and member engagement into a single unified system. Used by health plans, plan sponsors, and providers to administer pharmacy benefits across all 50 U.S. states.

2Assura
CategoryDrug Pricing and Cost Guarantee Solution
Description

Net cost guarantee pricing solution that locks in the net cost of drugs through annual fixed per-script pricing, covering entire populations including specialty medications. Includes quarterly reconciliation payments and protects health plans from drug-mix changes, inflation, and other cost factors. Designed for health plan payers seeking predictable drug spend.

3Better Balance
CategoryClinical Care Program
Description

AI-powered cardiometabolic care program developed in partnership with Welldoc, integrating AI-powered digital health tools with real-time clinical data to improve chronic condition management and medication adherence. Designed for health plan members managing cardiometabolic conditions.

4Better Access
CategorySpecialty Pharmacy Fulfillment Program
Description

Specialty pharmacy fulfillment program delivered through partnerships with Free Market Health and Amazon Pharmacy, expanding lower-cost access channels and improving pricing transparency for specialty medications. Enhances patient experience through streamlined fulfillment and home delivery.

5Triple-S en Casa
CategoryHome Delivery Pharmacy Program
Description

Home delivery pharmacy program launched in partnership with Triple-S and Alivia Home Delivery, Puerto Rico's first such program, providing members with a mobile app for prescription ordering and home delivery. Designed to improve medication access and adherence.

6Connected Specialty Care Network
CategorySpecialty Pharmacy Network
Description

LucyRx's specialty pharmacy network combined with Abarca's Darwin platform through the announced 2026 merger, providing integrated specialty medication management and care coordination across the combined entity serving 9+ million members.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-17
Description

Strategic combination announced June 17, 2026, to form Healthcare Revolution Partners as parent company. The merger creates a combined entity serving over 9 million plan members across the United States, combining Abarca's Darwin Healthcare Intelligence platform with LucyRx's clinical capabilities and Connected Specialty Care Network. Expected to close Q3 2026 pending regulatory approval.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-16
Description

Partnership for Better Balance program, an AI-powered cardiometabolic care solution using digital health tools and real-time clinical data to improve chronic condition management for members.

3Free Market Health
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-16
Description

Partnership for Better Access program to streamline specialty pharmacy fulfillment, expand lower-cost access channels, and improve pricing transparency for specialty medications.

newsismybusiness.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-16
Description

Partnership for Better Access program to enhance specialty pharmacy fulfillment and expand home delivery options through Amazon Pharmacy's logistics capabilities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-10-01
Description

Value-based agreement for Avonex (interferon beta-1a) and Tecfidera (dimethyl fumarate), specialty MS medications. Biogen provides rebates for discontinued treatment, demonstrating commitment to product effectiveness. This was the first publicly disclosed value-based contract to cover Medicaid patients, managed through Darwin platform's advanced reporting capabilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Launched Triple-S en Casa, Puerto Rico's first home delivery pharmacy program. Partnership enabled 151% of initial registered user goals within 30 days of COVID-19 launch, with 60% of prescriptions being 90-day supplies.

7Alivia Home Delivery
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Local pharmacy network partner for Triple-S en Casa home delivery program in Puerto Rico, ensuring members receive pharmacy services when and where they need them.

abarcahealth.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest independent, privately held PBMs in the U.S. serving health plans, employers, and government programs. Closely comparable to Abarca as a transparent, independent alternative to Big Three PBMs at meaningful scale.

TypeBroad incumbent
Description

One of the Big Three PBMs controlling ~80% of the U.S. PBM market alongside Caremark and OptumRx. Directly comparable to Abarca as a full-service PBM serving commercial, Medicare, and government clients, but vastly larger in scale and owned by a vertically integrated carrier.

3RxBenefits
TypeOthers
Description

Pharmacy benefit optimizer serving self-insured employers, partnering with PBMs to negotiate and administer benefits. Adjacent to Abarca in the PBM ecosystem, serving similar plan sponsors but as a broker/administrator rather than a direct PBM platform.

TypeBroad incumbent
Description

One of the Big Three PBMs and part of vertically integrated CVS Health. Comparable to Abarca as a full-service PBM serving commercial and government clients, with vastly greater scale and integrated retail pharmacy and clinical assets.

TypeBroad incumbent
Description

Owned by Humana and a meaningful PBM serving Medicare Advantage and commercial members. Comparable to Abarca in serving Medicare-led populations, though narrower in commercial book and tied to a single payer parent.

TypeEmerging player
Description

Technology-led transparent PBM targeting self-insured employers with modern software and pass-through pricing. Comparable to Abarca in transparent PBM positioning and tech-first go-to-market, though more narrowly focused on the employer segment.

TypeEmerging player
Description

Tech-forward PBM operating JUDI, a proprietary enterprise pharmacy platform, focused on transparency and modern technology. Comparable to Abarca in positioning as a technology-led, transparent PBM alternative, though smaller in scale.

TypeDirect peer
Description

Independent PBM owned by a consortium of Blue Cross Blue Shield plans, providing full-service PBM to Blues and other clients. Closely comparable to Abarca as a scaled independent alternative to the Big Three with deep Blue plan relationships.

TypeDirect peer
Description

Independent, pass-through PBM owned by SSM Health and Costco, focused on transparent pricing and clinical programs. Comparable to Abarca in offering an alternative to spread-pricing incumbents with similar client base among health plans and plan sponsors.

TypeBroad incumbent
Description

The largest of the Big Three PBMs, embedded within UnitedHealth Group and Optum. Directly comparable to Abarca in core PBM services and analytics, but with materially larger scale, integrated payer/provider assets, and broader clinical capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Abarca Health

Pharmacy Benefit Managementabarcahealth.com

Abarca Health is an independent, Puerto Rico-based pharmacy benefit manager that uses its proprietary Darwin platform to manage $14B in annual drug spend for 7.5M lives across commercial, Medicare, and Medicaid health plans in all 50 U.S. states.

What Abarca Health does

Abarca Health, founded in 2005 and headquartered in San Juan, Puerto Rico, is an independent, privately-held pharmacy benefit manager (PBM) serving commercial health plans, Medicare Advantage plans, Medicaid programs, and self-insured employers across all 50 U.S. states. The company manages approximately $14 billion in annual drug spend for 7.5 million lives and processes 220 million prescription claims per year, positioning itself as a transparent, non-spread-pricing alternative to the three dominant vertically-integrated PBMs (CVS Caremark, Express Scripts, OptumRx) that collectively control roughly 80% of the U.S. market.

Abarca's core technology is Darwin, a proprietary, cloud-based, in-house-built next-generation PBM platform that unifies claims processing, rebate administration, payments, invoicing, clinical tools, analytics, and member engagement into a single integrated system. The platform incorporates AI-powered clinical reasoning for prior authorization, predictive analytics over five years of historical utilization data, real-time benefit decision support, and adherence anomaly detection. Darwin is supplemented by Assura, a net cost guarantee pricing model that fixes per-script drug costs annually with quarterly reconciliation; RxTarget for medication adherence targeting; RxIntelligence reporting; and Coverage Determinations modules. In December 2025, Abarca launched two new Better Care programs — Better Balance (AI-powered cardiometabolic care in partnership with Welldoc) and Better Access (specialty pharmacy fulfillment in partnership with Free Market Health and Amazon Pharmacy).

Abarca earns revenue through managed-services administrative fees, claims-processing fees, manufacturer rebates (including value-based contracts such as the pioneering 2017 Biogen Medicaid agreement for MS therapies), and Assura subscription-style net cost guarantee pricing. The company holds URAC PBM accreditation, HITRUST CSF certification, ISO 22301 business continuity certification, and HIPAA compliance. In June 2026, Abarca announced a strategic combination with LucyRx to form Healthcare Revolution Partners, scaling combined membership to 9M+ plan members across commercial and government clients, with the deal expected to close in Q3 2026 pending regulatory approval. The company employs 650+ people (35%+ fully remote), with a secondary office in Florida, and is led by founder and CEO Jason Borschow alongside COO Adriana Ramirez, CTO Juan C. Ruiz, CIO Serge Perras, CPO Mercibel Gonzalez, and CGO Javier Gonzalez.

Abarca Health firmographics

Firmographics
Name
Abarca Health
Legal name
Abarca Health, LLC
Website
https://abarcahealth.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Abarca Health is an independent, Puerto Rico-based pharmacy benefit manager that uses its proprietary Darwin platform to manage $14B in annual drug spend for 7.5M lives across commercial, Medicare, and Medicaid health plans in all 50 U.S. states.
Ownership category
akta.pro rank

Abarca Health industry classification

Industry
Product category
Pharmacy Benefit Management
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Hospital & Medical Service Plans (6324)
akta.pro industry
PRIMARYHLAEAKAC
Claims Processing, Adjudication & Payment Integrity
SECONDARYHLAEAKAE
Specialty Pharmacy Benefit Management (Specialty PBM)

Keywords

  • Pharmacy benefit management
  • Drug spend management
  • Prescription claims processing
  • Specialty pharmacy services
  • PBM technology platform

Where Abarca Health is headquartered

Location

Headquarters

HQ city
San Juan Capistrano
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Abarca Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmacy Benefit Management Services: Abarca earns revenue by managing prescription drug benefits for health plans, self-insured employers, and government programs. Revenue is generated through administrative fees, claims processing fees, and rebates negotiated with pharmaceutical manufacturers.
  2. Net Cost Guarantee (Assura): Abarca guarantees net cost of drugs through annual fixed per-script pricing, with quarterly reconciliation payments to clients. This creates predictable drug spend management revenue while aligning incentives.
  3. Value-Based Agreements: Outcome-based contracts with pharmaceutical manufacturers where rebates are tied to medication adherence and patient outcomes, particularly for specialty medications.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels5 records

Abarca Health product offering

Product offering

Core offering

Abarca Health is a privately held pharmacy benefit manager (PBM) that manages prescription drug benefits for commercial health plans, Medicare and Medicaid programs, and self-insured employers across the United States. Its core offering is Darwin, a proprietary cloud-based PBM platform built in-house that integrates claims processing, rebate administration, payments, invoicing, clinical tools, predictive analytics, and member engagement. Complementing the platform are Assura net-cost-guarantee pricing, the Better Balance AI-powered cardiometabolic care program, the Better Access specialty pharmacy fulfillment program, and the Triple-S en Casa home delivery pharmacy program.

Product overview

Abarca Health operates as a pharmacy benefit manager (PBM) offering a unified platform-plus-modules architecture. The core offering centers on Darwin, a proprietary next-generation PBM platform that integrates claims processing, rebates, payments, clinical tools, and analytics. This platform is complemented by financial tools (Assura for net cost guarantees), clinical programs under the Better Care umbrella (Better Balance for AI-powered cardiometabolic care, Better Access for specialty pharmacy fulfillment), and additional modules including RxIntelligence for reporting, RxTarget for adherence, Coverage Determinations, and a home delivery app. Following the June 2026 merger with LucyRx, the combined entity now also incorporates LucyRx's Connected Specialty Care Network, serving over 9 million members across commercial and government clients under parent company Healthcare Revolution Partners.

Differentiator

Problem solved

Functional benefit

Brands

  • Darwin: Next-generation PBM platform that is fully integrated and user-friendly, providing business intelligence, claims processing, and reporting capabilities.
  • Assura
  • Better Care
  • RxTarget
  • Triple-S en Casa
  • Better Balance
  • Better Access

Products and services

  • Darwin Abarca's next-generation, cloud-based PBM platform built in-house for intelligent, flexible, and user-friendly pharmacy benefit management. Integrates claims processing, rebates, payments, clinical tools, analytics with five years of historical data, and member engagement into a single unified system. Used by health plans, plan sponsors, and providers to administer pharmacy benefits across all 50 U.S. states.
  • Assura Net cost guarantee pricing solution that locks in the net cost of drugs through annual fixed per-script pricing, covering entire populations including specialty medications. Includes quarterly reconciliation payments and protects health plans from drug-mix changes, inflation, and other cost factors. Designed for health plan payers seeking predictable drug spend.
  • Better Balance AI-powered cardiometabolic care program developed in partnership with Welldoc, integrating AI-powered digital health tools with real-time clinical data to improve chronic condition management and medication adherence. Designed for health plan members managing cardiometabolic conditions.
  • Better Access Specialty pharmacy fulfillment program delivered through partnerships with Free Market Health and Amazon Pharmacy, expanding lower-cost access channels and improving pricing transparency for specialty medications. Enhances patient experience through streamlined fulfillment and home delivery.
  • Triple-S en Casa Home delivery pharmacy program launched in partnership with Triple-S and Alivia Home Delivery, Puerto Rico's first such program, providing members with a mobile app for prescription ordering and home delivery. Designed to improve medication access and adherence.
  • Connected Specialty Care Network LucyRx's specialty pharmacy network combined with Abarca's Darwin platform through the announced 2026 merger, providing integrated specialty medication management and care coordination across the combined entity serving 9+ million members.

Quantifiable outcome

  • $14 billion in annual drug spend managed
  • +5 more outcomes

Companies that use Abarca Health

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Abarca Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature8 records

Abarca Health partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • LucyRxcoreStrategic or Co-development Partner · 17 June 2026Strategic combination announced June 17, 2026, to form Healthcare Revolution Partners as parent company. The merger creates a combined entity serving over 9 million plan members across the United States, combining Abarca's Darwin Healthcare Intelligence platform with LucyRx's clinical capabilities and Connected Specialty Care Network. Expected to close Q3 2026 pending regulatory approval.
  • WelldoccoreStrategic or Co-development Partner · 16 December 2025Partnership for Better Balance program, an AI-powered cardiometabolic care solution using digital health tools and real-time clinical data to improve chronic condition management for members.
  • Free Market HealthcoreTechnology or Integration · 16 December 2025Partnership for Better Access program to streamline specialty pharmacy fulfillment, expand lower-cost access channels, and improve pricing transparency for specialty medications.
  • Amazon PharmacycoreTechnology or Integration · 16 December 2025Partnership for Better Access program to enhance specialty pharmacy fulfillment and expand home delivery options through Amazon Pharmacy's logistics capabilities.
  • Biogen Inc.coreStrategic or Co-development Partner · 1 October 2017Value-based agreement for Avonex (interferon beta-1a) and Tecfidera (dimethyl fumarate), specialty MS medications. Biogen provides rebates for discontinued treatment, demonstrating commitment to product effectiveness. This was the first publicly disclosed value-based contract to cover Medicaid patients, managed through Darwin platform's advanced reporting capabilities.
  • Triple-ScoreStrategic or Co-development PartnerLaunched Triple-S en Casa, Puerto Rico's first home delivery pharmacy program. Partnership enabled 151% of initial registered user goals within 30 days of COVID-19 launch, with 60% of prescriptions being 90-day supplies.
  • Alivia Home DeliveryminorChannel Partner/ Reseller/ DistributorLocal pharmacy network partner for Triple-S en Casa home delivery program in Puerto Rico, ensuring members receive pharmacy services when and where they need them.

Scale indicators8 records

Recent moves7 records

Expansion highlights7 records

Abarca Health competitors and assessment

Company assessment

Direct peers

  • MedImpact Healthcare Systems: One of the largest independent, privately held PBMs in the U.S. serving health plans, employers, and government programs. Closely comparable to Abarca as a transparent, independent alternative to Big Three PBMs at meaningful scale.
  • Prime Therapeutics: Independent PBM owned by a consortium of Blue Cross Blue Shield plans, providing full-service PBM to Blues and other clients. Closely comparable to Abarca as a scaled independent alternative to the Big Three with deep Blue plan relationships.
  • Navitus Health Solutions: Independent, pass-through PBM owned by SSM Health and Costco, focused on transparent pricing and clinical programs. Comparable to Abarca in offering an alternative to spread-pricing incumbents with similar client base among health plans and plan sponsors.

Broad incumbents

  • Express Scripts (Cigna): One of the Big Three PBMs controlling ~80% of the U.S. PBM market alongside Caremark and OptumRx. Directly comparable to Abarca as a full-service PBM serving commercial, Medicare, and government clients, but vastly larger in scale and owned by a vertically integrated carrier.
  • CVS Caremark: One of the Big Three PBMs and part of vertically integrated CVS Health. Comparable to Abarca as a full-service PBM serving commercial and government clients, with vastly greater scale and integrated retail pharmacy and clinical assets.
  • Humana Pharmacy Solutions: Owned by Humana and a meaningful PBM serving Medicare Advantage and commercial members. Comparable to Abarca in serving Medicare-led populations, though narrower in commercial book and tied to a single payer parent.
  • OptumRx (UnitedHealth Group): The largest of the Big Three PBMs, embedded within UnitedHealth Group and Optum. Directly comparable to Abarca in core PBM services and analytics, but with materially larger scale, integrated payer/provider assets, and broader clinical capabilities.

Others

  • RxBenefits: Pharmacy benefit optimizer serving self-insured employers, partnering with PBMs to negotiate and administer benefits. Adjacent to Abarca in the PBM ecosystem, serving similar plan sponsors but as a broker/administrator rather than a direct PBM platform.

Emerging players

  • SmithRx: Technology-led transparent PBM targeting self-insured employers with modern software and pass-through pricing. Comparable to Abarca in transparent PBM positioning and tech-first go-to-market, though more narrowly focused on the employer segment.
  • Capital Rx: Tech-forward PBM operating JUDI, a proprietary enterprise pharmacy platform, focused on transparency and modern technology. Comparable to Abarca in positioning as a technology-led, transparent PBM alternative, though smaller in scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Abarca Health social profiles

Digital presence

Abarca Health compliance and trust

Trust signal

Compliance6 records

Abarca Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Abarca Health leadership team

Management profile

Number of profiles

Profiles15 records

Abarca Health subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Abarca Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Abarca Health M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abarca Health

What does Abarca Health do?

Abarca Health is a privately held pharmacy benefit manager (PBM) that manages prescription drug benefits for commercial health plans, Medicare and Medicaid programs, and self-insured employers across the United States. Its core offering is Darwin, a proprietary cloud-based PBM platform built in-house that integrates claims processing, rebate administration, payments, invoicing, clinical tools, predictive analytics, and member engagement. Complementing the platform are Assura net-cost-guarantee pricing, the Better Balance AI-powered cardiometabolic care program, the Better Access specialty pharmacy fulfillment program, and the Triple-S en Casa home delivery pharmacy program.

Is Abarca Health a public or private company?

Abarca Health is a private company. It is classified as corporate owned and is currently operating.

When was Abarca Health founded?

Abarca Health was founded in 2005. It employs 501 to 1,000 people.

Where is Abarca Health based?

Abarca Health is headquartered in San Juan Capistrano, United States, in the North America region.

How does Abarca Health make money?

Three revenue lines are on record. Pharmacy Benefit Management Services are the primary driver. The others are net Cost Guarantee (Assura) and value-Based Agreements.

Who are Abarca Health's main competitors?

Direct peers on record are MedImpact Healthcare Systems, Prime Therapeutics and Navitus Health Solutions. Broad incumbents are Express Scripts (Cigna), CVS Caremark, Humana Pharmacy Solutions and OptumRx (UnitedHealth Group). RxBenefits is listed as an others. Emerging players are SmithRx and Capital Rx.

Does Abarca Health have an API?

No public API is recorded for Abarca Health.

What industry is Abarca Health in?

Abarca Health's product category is Pharmacy Benefit Management. Its primary akta.pro industry code is HLAEAKAC, Claims Processing, Adjudication & Payment Integrity, with a secondary code of HLAEAKAE, Specialty Pharmacy Benefit Management (Specialty PBM). Its NAICS code is 524292 and its SIC code is 6324.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FierceHealthcareRedesigning prior authorization around the patientAbarca Health's Adriana Ramirez discusses redesigning prior authorization around the patient in a sponsored Podnosis episode. The framework emphasizes experience, infrastructure, and performance, urging decision support closer to prescribing and shared standards. Progress depends on trust, accountability, and collaboration across the healthcare ecosystem.FierceHealthcareAs PBM industry shifts, LucyRx and Abarca Health merge to build scaleLucyRx and Abarca Health announced plans to merge, creating Healthcare Revolution Partners as their parent organization, with the deal expected to close in Q3 2026 pending regulatory approval. The combined organization will serve more than 9 million members across the country. The merger aims to build the scale necessary to compete as rising healthcare costs, particularly around GLP-1 drugs, push more employers and plans to seek alternatives to traditional vertically integrated PBMs.MedCity NewsAbarca Health and LucyRx to Combine to Scale Independent PBM ModelAbarca Health and LucyRx announced they are combining to form an independent pharmacy benefit manager under parent company Healthcare Revolution Partners, supporting over 9 million members across commercial and government clients. The merger, pending regulatory approval and expected to close in Q3 2026, positions the combined entity to compete against the dominant "Big Three" PBMs as the industry faces increased federal and state scrutiny and reform. The companies view the regulatory changes, including the Consolidated Appropriations Act of 2026 and state-level PBM legislation, as a disruptive tailwind favoring independent players.BioSpaceAbarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government ScaleAbarca Health and LucyRx announced a strategic combination to form the only modern, independent pharmacy benefit manager capable of serving commercial and government clients at scale. The combined entity will serve over 9 million members in the United States and operate as wholly owned subsidiaries of Healthcare Revolution Partners pending regulatory approval expected in Q3 2026. This merger aims to leverage Abarca's technology platform and LucyRx's clinical capabilities to address rising drug costs and evolving regulatory demands.AijournAbarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government ScaleAbarca Health and LucyRx announced a strategic combination to form a modern, independent pharmacy benefit manager under Healthcare Revolution Partners, creating an entity serving over 9 million members across the United States. The combined company will maintain both brands as wholly owned subsidiaries while expanding capabilities to serve both commercial and government clients at scale. The transaction is expected to close in Q3 2026, pending regulatory approvals, with current leadership continuing in their respective roles.PR NewswireAbarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government ScaleAbarca Health and LucyRx announced a strategic combination to create a modern, independent pharmacy benefit manager (PBM) serving both commercial and government clients, with the combined entity operating as subsidiaries of newly formed Healthcare Revolution Partners. The merged company will provide prescription services to more than 9 million members across the United States and bring together Abarca's Darwin Healthcare Intelligence platform with LucyRx's clinical capabilities and Connected Specialty Care Network. The transaction, expected to close in Q3 2026, is subject to regulatory approvals and customary closing conditions, with both companies remaining independently owned and operated until closing.ForbesAbarca Health And LucyRx To Merge Into Alternative To Big Three PBMsAbarca Health and LucyRx, two privately held independent pharmacy benefit management companies, have agreed to merge as an alternative to the nation\'s three largest PBMs that control 80% of the U.S. market. The combined entity will serve more than 9 million plan members across all 50 states under the new parent company Healthcare Revolution Partners, with the deal expected to close in Q3 2026 pending regulatory approvals. The merger positions the companies as a transparent, non-vertically integrated option at a time when PBMs face unprecedented regulatory scrutiny and pressure from policymakers seeking lower prescription drug prices.AbarcahealthAbarca Health and LucyRx Announce Strategic CombinationAbarca Health and LucyRx announced a strategic combination to create a modern independent pharmacy benefit manager. The combined entity will serve over 9 million members across the U.S., with the deal expected to close in the third quarter of 2026.YahooAbarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government ScaleAbarca Health and LucyRx announced a strategic combination to create a modern PBM for commercial and government clients. Combined, they will serve over 9 million members across the United States. Both brands will remain in place as wholly owned subsidiaries of Healthcare Revolution Partners.MedCity NewsMedCity Pivot Podcast: Modernizing Prior AuthA MedCity Pivot podcast episode features Javier Gonzalez of Abarca Health and Tanvi Patel of Amazon Pharmacy discussing modernizing prior authorization. They highlight challenges like policy complexity, data quality, and operational risk, and note that electronic prior authorizations can save 60-70% of effort. They expect regulations to expand beyond medical procedures to pharmacy drugs.